Based on this knowledge, Allison’s group proposed that the blockade of CTLA-4 could boost the amplitude of CD8+ T cell activation thereby achieving a better CD8+ T cell-mediated tumour eradication. The gene discussed is CD8A; the disease is neoplasm.